WisdomInterface
WisdomInterface

ENDOZYME® II GO : Recombinant Factor c (rFC) in routine use

December 1, 2020
1 min read

Interview with Dr. Tony Dinis, Pharmaceutical Microbiologist at Ceva

The ENDONEXT™ EndoZyme® II assay is the enhanced second generation of EndoZyme®, based on recombinant Factor C (rFC), the synthetic analogue to the native endotoxin-specific principal receptor in the Limulus Amebocyte Lysate (LAL) cascade. Instead of being based on an animal source, EndoZyme® II is a sustainable alternative method in line with regulatory requirements. EndoZyme® II is particularly suited for end-product testing and in-process control of water and raw materials, as well as medical device testing.

Watch now to learn more.

Uncategorized

    Watch Now










    I agree to receive marketing communication from bioMérieux. By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy. You may opt-out at any time.

    SUBSCRIBE
    Image Processing

    Who We Are

    Xcellent Insights is a futuristic market intelligence firm, headquartered in New York, US that focuses on providing strategic market insights. We offer a plethora of data-centric research reports and consulting services to help customers expand and explore their business strategies, obtain clarity about current business trends and future development, and attain substantial growth. Our portfolio of services includes syndicated and custom research reports driven by end-to-end market research and market intelligence studies.

    What We Do

    We strive to offer the best market research and consulting services to our customers that will benefit them in making informed business decisions. We provide an extensive list of market research titles falling under various industry categories such as consumer goods, food, and beverages, automotive, healthcare, and chemicals, covering latest and trending market insights. Through our services, we aim to connect an organization’s goal with lucrative outcomes globally.

      Subscribe for more insights



      By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

      No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.

        Subscribe for more insights



        By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

        No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.